tradingkey.logo
tradingkey.logo
Search

24H | Novo Nordisk Soars 10% on Approval for Weight-Loss Pill; Zim Integrated Shipping Rocks 11%; Space Stocks Pull Back With LUNR, RKLB Down 5% Each

TigerDec 23, 2025 1:18 AM
facebooktwitterlinkedin
View all comments0

Novo Nordisk shares jumped nearly 10% in overnight trading. The U.S. Food and Drug Administration approved Novo Nordisk's weight-loss pill on Monday, giving the Danish drugmaker a leg up in the race to market a potent oral medication for shedding pounds as it looks to regain lost ground from rival Eli Lilly.

Shares of Zim Integrated Shipping Services shares rose 11% in overnight trading after the company said it had received several acquisition proposals.

The Israel-based logistics provider said the board of directors has received competitive proposals from multiple strategic partners to acquire the company. The proposals were part of a review of strategic alternatives that Zim has been undergoing.

Space stocks pulled back with Sidus Space down 35%; LUNR, RKLB down 5% each; Redwire down nearly 3%.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.